SCHEMBL6936648

SCHEMBL6936648

CCCCN(C1CC(C)(C)c2ccc([N+](=O)[O-])cc21)S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 10/20 0.40
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
ESPL1 Q14674 1/20 0.35
VCAM1 P19320 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TBXA2R P21731 2/20 0.33
ADRA2A P08913 1/20 0.33
PNMT P11086 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931992 0.80 CYP19A1 (0.40) CYP19A1LMNAALDH1A1
SCHEMBL6930525 0.80 POLB (0.37) CYP19A1MAPTALDH1A1
SCHEMBL6932378 0.76 CNR2 (0.37) SMN1; SMN2
SCHEMBL8180505 0.76 CYP19A1 (0.42) CYP19A1MAPTALDH1A1TBXA2RSLC6A2
SCHEMBL6935322 0.75 CYP19A1 (0.39) CYP19A1MAPTLMNAHTTVCAM1
SCHEMBL6342196 0.75 CYP19A1 (0.37) CYP19A1MAPTTBXA2RSLC6A2SLC6A4
SCHEMBL6935009 0.69 CYP19A1 (0.39) CYP19A1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL6938882 0.68 CYP3A4 (0.44) MAPTLMNAALDH1A1SMN1; SMN2ADRA2A
SCHEMBL9156355 0.68 HIF1A (0.46) MAPTLMNAALDH1A1SMN1; SMN2PNMT
SCHEMBL6936617 0.68 KCNE1 (0.53) LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915087-B1 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them AVENTIS PHARMA GMBH (DE) 2003-04-02 EP disclosed
US-6015822-A ANTIULCER, ANTIDIARRHEA, AND ANTIARRHYTHMIA AGENTS; CARDIOVASCULAR AND GASTROINTESTINAL DISORDERS HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) 2000-01-18 US disclosed
EP-0915087-A2 Sulfonamide substituted fused five-membered ring compounds, their use as medicaments as well as pharmaceutical compositions containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-05-12 EP disclosed